UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057014
Receipt number R000065162
Scientific Title Investigating the effects of Tactile Care on reducing anxiety in mothers of children with developmental disorders
Date of disclosure of the study information 2025/02/15
Last modified on 2025/02/13 15:18:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the effects of Tactile Care for mothers of children with developmental disorders

Acronym

Effects of Tactile Care

Scientific Title

Investigating the effects of Tactile Care on reducing anxiety in mothers of children with developmental disorders

Scientific Title:Acronym

The anxiety-reducing effect of Tactile Care

Region

Japan


Condition

Condition

Mother of a child with developmental disabilities

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate the physiological and psychological effects on mothers of children with developmental disorders who receive Tactile Care.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase I


Assessment

Primary outcomes

1.Tactile Care has an effect on physiological indicators such as body temperature, breathing, heart rate, time to fall asleep, and sleep time after the intervention.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Maneuver

Interventions/Control_1

Intervention period: The therapist provide Tactile Care to the participant's back every other week. (for 3 months, 6 times)

Interventions/Control_2

Non-intervention period: Participants sit quietly for 10 minutes every other week. (for 3 months, 6 times)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit

39 years-old >=

Gender

Female

Key inclusion criteria

1.Participants are mothers of children with developmental disorders. (elementary and junior high school students)
2.Mothers can participate in the measurements. (every other week)
3.Participants can wear the measurement device on their wrists and install the app on their smartphones. (6 months)
4.Participants can have the therapist touch their back.

Key exclusion criteria

The exclusion criteria are as follows: pregnant or possibly pregnant, uncomfortable with being touched, no experience of bring up after a child with a developmental disorder, currently undergoing treatment for depression.

Target sample size

6


Research contact person

Name of lead principal investigator

1st name Chieko
Middle name
Last name Takasuka

Organization

Kanon Matsuyama Co., Ltd, Matsuyama, Japan

Division name

Davelopment of support room Dekopon

Zip code

791-8013

Address

5-8-6, Yamagoe, Matsuyama-shi, Ehime, Japan

TEL

089-925-2525

Email

ruihimepom@gmail.com


Public contact

Name of contact person

1st name Chieko
Middle name
Last name Takasuka

Organization

Kanon Matsuyama Co., Ltd, Matsuyama, Japan

Division name

Davelopment of support room Dekopon

Zip code

791-8013

Address

5-8-6, Yamagoe, Matsuyama-shi, Ehime, Japan

TEL

089-925-2525

Homepage URL


Email

ruihimepom@gmail.com


Sponsor or person

Institute

Kanon Matsuyama Co., Ltd, Matsuyama, Japan

Institute

Department

Personal name



Funding Source

Organization

Kanon Matsuyama Co., Ltd, Matsuyama, Japan

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kanon Matsuyama Co., Ltd, Matsuyama, Japan

Address

5-8-6, Yamagoe, Mtauyama-shi, Ehime, Japan

Tel

089-925-2525

Email

ruihimepom@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

発達支援ルームでこポン(愛媛県)   Development of sapport room Dekopon(Ehime)


Other administrative information

Date of disclosure of the study information

2025 Year 02 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

6

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 01 Month 30 Day

Date of IRB

2025 Year 01 Month 30 Day

Anticipated trial start date

2025 Year 03 Month 01 Day

Last follow-up date

2025 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 02 Month 13 Day

Last modified on

2025 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065162